Drug Engine Pharma Revs Up for ChemOutsourcing 2022

Drug Engine Pharma is gearing up for ChemOutsourcing 2022, the longest-running US-based API show, which will be held on September 7-9 at the Hilton Hotel in Parsippany, New Jersey. At least 700 individuals from the pharmaceutical, biotech, and chemistry service industries are expected to attend, creating opportunities for networking and partnerships. Drug Engine Pharma’s participation will highlight its unique services catering to innovators struggling to outsource to multiple service providers.

Dhileep Krishnamurthy, Drug Engine Pharma’s CSO and Head of CMC, will join other drug development experts from TCG GreenChem, Crystal Pharmatech, Syner-G BioPharma Group, and Arvinas in a panel discussion on “Choosing the Right CDMO for Biotechs: Past, Present, and Future” on September 7. He and John Bolesta, Drug Engine Pharma’s CEO, will also hold a 15-minute talk titled “Our Fit-for-Purpose Model with Case Studies” on September 8 at 8:15 AM. The discussion will center around a system of finding the right vendors specializing in different areas of drug development to address the innovator’s specific needs.

Drug Engine Pharma will be exhibiting at Booth 91, where Bolesta and Krishnamurthy will meet and spend time with attendees as part of their efforts to share insights, learn from others, and create opportunities for collaboration and innovation. “DEP’s goal is to meet other potential partners and introduce ourselves to innovators looking to outsource to multiple vendors,” said Bolesta. “Our unique collaborative model has been helping many reduce costs and accelerate timelines, so we would like to share this option with others

looking for a more streamlined approach,” he added.

Other activities will also be done at the 3-day event, including exhibits and socials. To know more about Drug Engine Pharma, visit its LinkedIn page for updates about its happenings at ChemOutsourcing 2022.